The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study
Abstract
BACKGROUND: Men treated for clinically localized prostate cancer with either radical prostatectomy or external beam radiotherapy usually survive many years with the side effects of these treatments. We present treatment-specific quality-of-life outcomes for prostate cancer patients 5 years after initial diagnosis. METHODS: The cohort consisted of men aged 55-74 years who were newly diagnosed with clinically localized prostate cancer in 1994-1995 and were treated with radical prostatectomy (n = 901) or external beam radiotherapy (n = 286). We used clinical and quality-of-life data previously collected at the time of diagnosis (i.e., baseline) and at the 2-year follow-up and data newly collected at 5 years after diagnosis to compare urinary, bowel, and sexual function and to examine temporal changes in those functions. Odds ratios (ORs) and adjusted percentages were calculated by logistic regression. All statistical tests were two-sided. RESULTS: At 5 years after diagnosis, overall sexual function declined in both groups to approximately the same level. However, at 5 years after diagnosis, erectile dysfunction was more prevalent in the radical prostatectomy group than in the external beam radiotherapy group (79.3% versus 63.5%; OR = 2.5, 95% confidence interval [CI] = 1.6 to 3.8). Approximately 14%-16% of radical prostatectomy and 4% of external beam radiotherapy patients were incontinent at 5 years (OR = 4.4, 95% CI = 2.2 to 8.6). Bowel urgency and painful hemorrhoids were more common in the external beam radiotherapy group than in the radical prostatectomy group. All of these differences remained statistically significant after adjustment for confounders and for differences between treatment groups in some baseline characteristics. CONCLUSIONS: At 5 years after diagnosis, men treated with radical prostatectomy for localized prostate cancer continue to experience worse urinary incontinence than men treated with external beam radiotherapy. However, the two treatment groups were more similar to each other with respect to overall sexual function, mostly because of a continuing decline in erectile function among the external beam radiotherapy patients between years 2 and 5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For early stage cancer, primary treatment options are radical prostatectomy, radiation therapy, and active surveillance, which can lead to differences in specific areas of functioning, such as sexual, urinary or bowel functioning over time [2, 3].”
From Prostate cancer: Psychosocial implications and management (2008) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. V. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 3,104
Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
Rosenbaum, P. R., & Rubin, D. B. (1984) · Journal of the American Statistical Association · doi:10.1080/01621459.1984.10478078 · Cited by 3,082
Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate Cancer
Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., Albertsen, P. C., Harlan, L. C., & Potosky, A. L. (2000) · JAMA · doi:10.1001/jama.283.3.354 · Cited by 1,187
Self-citationPredictive Margins with Survey Data
Graubard, B. I., & Korn, E. L. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00652.x · Cited by 875
The UCLA Prostate Cancer Index
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., LEAKE, B. D., & Brook, R. H. (1998) · Medical Care · doi:10.1097/00005650-199807000-00007 · Cited by 819
A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill‐Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 809
Quality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 710
Fleming, C. (1993) · JAMA · doi:10.1001/jama.269.20.2650 · Cited by 565
Research works printed but not linked: 1
- Fleming, 1993, JAMA, 269, 2650, 10.1001/jama.1993.03500200064035 · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 679
Drummond, F. J., O’Leary, E., Gavin, A., Kinnear, H., & Sharp, L. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-3033-x · Cited by 7
The Effect of Targeted Therapy for Genitourinary Malignancies on Sexual Function and Fertility
Holland, B. C., Shetty, Z., & Alanee, S. R. (2017) · Current Urology Reports · doi:10.1007/s11934-017-0704-9 · Cited by 7
Hewson, E. A., Ge, Y., O'Brien, R. T., Roderick, S., Bell, L., Poulsen, P. R., Eade, T., Booth, J., Keall, P., & Nguyen, D. T. (2020) · Medical Physics · doi:10.1002/mp.14572 · Cited by 7
Walker, L. M., Beck, A. M., Hampton, A. J. D., & Robinson, J. W. (2014) · Canadian Oncology Nursing Journal · doi:10.5737/1181912x244256263 · Cited by 7
Hormonal Changes and Sexual Dysfunction
Zhou, E. S., Frederick, N. N., & Bober, S. L. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.06.008 · Cited by 7
Being There Is Important, but Getting There Matters Too: The Role of Path in the Valuation Process
Goldberg, J. H. (2006) · Medical Decision Making · doi:10.1177/0272989x06291680 · Cited by 7
Zhu, Z.-Y., Wang, X., & Li, D.-P. (2018) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2018.2545 · Cited by 7
RetractedInitial experience of transurethral ultrasound ablation of the prostate in Asia
Miura, M., Takahashi, S., Fukumoto, M., & Higashiyama, H. (2022) · BJUI Compass · doi:10.1002/bco2.175 · Cited by 6
Naccarato, A. M. E. P., Reis, L. O., Zani, E. L., Cartapatti, M., & Denardi, F. (2014) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2014.01.007 · Cited by 6
Salami, S. S., Obedian, E., Zimberg, S. H., & Olsson, C. A. (2016) · Advances in Radiation Oncology · doi:10.1016/j.adro.2016.10.005 · Cited by 6
Co‐designing an online treatment decision aid for men with low‐risk prostate cancer: Navigate
Schofield, P. E., Hyatt, A., White, A., White, F., Frydenberg, M., Chambers, S. K., Gardiner, R. A., Murphy, D. G., Cavedon, L., Millar, J. L., et al. (2023) · BJUI Compass · doi:10.1002/bco2.279 · Cited by 6
Ruiz-Aragón, J., Márquez-Peláez, S., & Romero, L. G. L. (2010) · Actas Urológicas Españolas (English Edition) · doi:10.1016/s2173-5786(10)70169-4 · Cited by 6
Physician Assessment of Pretreatment Functional Status: A Process-Outcomes Link
Chamie, K., Sadetsky, N., & Litwin, M. S. (2011) · The Journal of Urology · doi:10.1016/j.juro.2010.11.087 · Cited by 6
Quality of life before and after prostatectomy as treatment for localized cancer.
Ward-Smith, P. A., & Mehl, J. (2007) · PubMed · Cited by 6
Lee, H. J., Macomber, M. W., Spraker, M. B., Bowen, S. R., Hippe, D. S., Fung, A., Russell, K., Laramore, G. E., Rengan, R., Liao, J. J., et al. (2018) · Radiation Oncology · doi:10.1186/s13014-018-1127-6 · Cited by 6
The validity of the Distress Thermometer in female partners of men with prostate cancer
Hyde, M. K., Zajdlewicz, L., Lazenby, M., Dunn, J. C., Laurie, K., Lowe, A., & Chambers, S. K. (2018) · European Journal of Cancer Care · doi:10.1111/ecc.12924 · Cited by 6
Rosenbaum, C. M., Vetterlein, M. W., & Fisch, M. (2020) · Der Urologe · doi:10.1007/s00120-020-01167-z · Cited by 6
Screening for Prostate Cancer with Prostate-Specific Antigen: What's the Evidence?
Marcus, P. M., & Kramer, B. S. (2012) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2012.32.216 · Cited by 6
Groß, M., Awamlh, B. A. H. A., & Hu, J. C. (2019) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2019.05.007 · Cited by 6
Regan, T. W., Acquati, C., & Zimmerman, T. K. (2018) · Springer eBooks · doi:10.1007/978-3-319-77432-9_14 · Cited by 6
Ruiz-Aragón, J., Márquez-Peláez, S., & Romero, L. G. L. (2010) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2010.05.005 · Cited by 6
Cryotherapy for Prostate Cancer
Miller, D. C., Pisters, L. L., & Belldegrun, A. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00105-5 · Cited by 6
Improving Prostate-Specific Antigen Screening
Strope, S. A., & Andriole, G. L. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.9779 · Cited by 6
Estimation of Prostate Cancer Cost in Egypt From a Societal Perspective
Elsisi, G. H., Elattar, M., Ismaeil, S. M., El-Shater, M. E.-S., Kirollos, M., Sedrak, A., Morad, H., Abdel-Mohsen, H., Abdel-Aziz, M., Magdy, M., et al. (2023) · Global Journal on Quality and Safety in Healthcare · doi:10.36401/jqsh-22-20 · Cited by 5
Kosik, I., Weersink, R., & Wilson, B. C. (2022) · Novel Optical Systems, Methods, and Applications · doi:10.1117/12.2638115 · Cited by 5
Ailloud, A., Udrescu, C., Horn, S., Enachescu, C., Créhange, G., Sargos, P., Supiot, S., Zilli, T., Lapierre, A., & Chapet, O. (2023) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2023.07.010 · Cited by 5
Pelvic Floor Physical Therapy Interventions for Oncology Patients
Massa, L. A. (2011) · Topics in Geriatric Rehabilitation · doi:10.1097/tgr.0b013e3182198fc0 · Cited by 5
Prasad, V. K. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.05.019 · Cited by 5
Brandes, A., Koerber, F., Schwarzkopf, L., Hünger, M., Rogowski, W. H., & Waidelich, R. M. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1886-4 · Cited by 5
Surgical Reconstruction of Posterior Urethral Complications Following Prostate Cancer Treatments
Vetterlein, M. W., Rosenbaum, C. M., & Fisch, M. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-21447-0_25 · Cited by 5
Kinnaird, W., & Stewart-Lord, A. (2020) · Radiography · doi:10.1016/j.radi.2019.11.039 · Cited by 5
Ma, K., Song, P., Qing, Y., Li, Y., Shu, M., Yang, L., & Dong, Q. G. (2022) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1862_21 · Cited by 5
Schega, L., Törpel, A., Hein, N., Napiontek, A., Wenzel, C., & Becker, T. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.09.020 · Cited by 5
Weersink, R., Wilson, B. C., Bogaards, A., Gertner, M. R., Davidson, S. R. H., Haider, M. A., ELHILALI, M. M., & Trachtenberg, J. (2007) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.704398 · Cited by 5
Modeling recovery curves with application to prostatectomy
Wang, F., Rudin, C. D., McCormick, T. H., & Gore, J. L. (2018) · Biostatistics · doi:10.1093/biostatistics/kxy002 · Cited by 5
Reproductive Complications and Sexual Dysfunction in the Cancer Patient
Schover, L. R. (2006) · Springer eBooks · doi:10.1007/0-387-31056-8_90 · Cited by 5
Endocrine and Fertility Effects in Male Cancer Survivors
Thaler-DeMers, D. (2006) · AJN American Journal of Nursing · doi:10.1097/00000446-200603003-00023 · Cited by 5
Health-Related Quality of Life in Cancer Patients—More Answers but Many Questions Remain
Goodwin, P. J., & Sridhar, S. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp140 · Cited by 5
Daniels, J., Kyei, K. A., Frimpong-Boateng, P. D., & Nyantakyi, A. Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324662 · Cited by 4
Choi, E. Y., Jeong, J., Kang, D. I., Johnson, K. C., Jang, T. L., & Kim, I. Y. (2010) · Journal of Robotic Surgery · doi:10.1007/s11701-010-0212-0 · Cited by 4
McIntosh, M., Tiruye, T. Y., Ettridge, K. A., O’Callaghan, M. E., Jay, A., & Beckmann, K. (2025) · BMC Urology · doi:10.1186/s12894-025-01702-0 · Cited by 4
Eficacia de las intervenciones psicológicas en hombres con cáncer de próstata
Tabernero, N. O., Fuentes, M. S., Lentati, G. O., Velez, E. S. P., Cevas, F. J., & Pino, N. D. (2013) · Psicooncología · doi:10.5209/rev_psic.2013.v10.n2-3.43454 · Cited by 4
Soh, F.-Y., James, M. L., Hickey, B. E., Daly, T., Jeffery, M., See, A. M., & Francis, D. P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011462 · Cited by 4
Scott Dahlbeck Chase, C. (2014) · Journal of Nuclear Medicine & Radiation Therapy · doi:10.4172/2155-9619.1000215 · Cited by 4
Targeted Ablative Therapies for Prostate Cancer
Winoker, J. S., Anastos, H., & Rastinehad, A. R. (2018) · Cancer treatment and research · doi:10.1007/978-3-319-93339-9_2 · Cited by 4
van Wijk, Y., Ramaekers, B. L. T., Vanneste, B. G. L., Halilaj, I., Oberije, C., Chatterjee, A., Marcelissen, T. A. T., Jochems, A., Woodruff, H. C., & Lambin, P. (2021) · Cancers · doi:10.3390/cancers13112687 · Cited by 4
Validity Testing of the Stopwatch Urine Stream Interruption Test in Radical Prostatectomy Patients
Robinson, J. P., Burrell, S. A., Avi-Itzhak, T. E., & McCorkle, R. C. (2012) · Journal of Wound Ostomy and Continence Nursing · doi:10.1097/won.0b013e3182648055 · Cited by 4
Magnetic Resonance–Guided Prostate Ablation
Woodrum, D. A., Kawashima, A., Gorny, K. R., & Mynderse, L. A. (2019) · Seminars in Interventional Radiology · doi:10.1055/s-0039-1697001 · Cited by 4
Barry, M. J. (2010) · Complutensian Scientific Journals (Complutense University of Madrid) · doi:10.5209/rev_psic.2010.v7.n2.15876 · Cited by 4
Erektile Dysfunktion nach radikaler Prostatektomie
Kaufmann, S., Al‐Najar, A., Boy, S., Hamann, M. F., Naumann, C. M., Fritzer, E., Junemann, K. P., & van der Horst, C. (2009) · Der Urologe · doi:10.1007/s00120-009-2190-2 · Cited by 4
Ahn, J., Liu, S., Wang, W., & Yuan, Y. (2013) · Biometrics · doi:10.1111/biom.12100 · Cited by 4
Data Pooling and Analysis to Build a Preliminary Item Bank
Eton, D. T., Lai, J., Cella, D. F., Reeve, B. B., Talcott, J. A., Clark, J. A., McPherson, C. P., Litwin, M. S., & Moinpour, C. M. (2005) · Evaluation & the Health Professions · doi:10.1177/0163278705275338 · Cited by 4
Reliable Measurement in Urology: Room for Improvement
Gilbert, S. M. (2007) · European Urology · doi:10.1016/j.eururo.2007.04.032 · Cited by 4
Treatment for Postprostatectomy Incontinence
Penson, D. F. (2011) · JAMA · doi:10.1001/jama.2010.1984 · Cited by 4
Self-citationQuality of Life after Radical Prostatectomy: How to Preserve Potency?
Bollens, R., Roumeguère, T., Schulman, C. C., & Zlotta, A. R. (2005) · European Urology Supplements · doi:10.1016/j.eursup.2005.01.009 · Cited by 4
Evidence-based medicine in prostate cancer: where do we stand in 2006?
Dahm, P. (2006) · Current Opinion in Urology · doi:10.1097/01.mou.0000193395.00340.3e · Cited by 4
Treatment of Localized Prostate Cancer
Stephenson, A. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-900-6_14 · Cited by 4
Treating Older Men With Prostate Cancer
Litwin, M. S., & Miller, D. C. (2006) · JAMA · doi:10.1001/jama.296.22.2733 · Cited by 3
Massouh, K., Leucht, K., Leistritz, L., & Grimm, M. (2026) · International Journal of Urology · doi:10.1111/iju.70339 · Cited by 3
Patient-reported outcomes after prostate cancer treatment
Grover, S., Metz, J. M., Vachani, C. C., Hampshire, M. K., DiLullo, G. A., & Hill‐Kayser, C. E. (2014) · Journal of Clinical Urology · doi:10.1177/2051415814523269 · Cited by 3
Differences in health care professionals' and cancer patients' views on sexual health issues
Greimel, E., Lanceley, A., Oberguggenberger, A., Nordin, A. J., Kuljanić, K., Schmalz, C., Arrarás, J. I., Chie, W., Jensen, P. T., Tomaszewski, K. A., et al. (2018) · Psycho-Oncology · doi:10.1002/pon.4814 · Cited by 3
Lu, Y., Huang, H. H., & Lau, W. K. O. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02518-7 · Cited by 3
Prostate only radiotherapy using external beam radiotherapy: A clinician’s perspective
Lee, J. W., & Chung, M. J. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i29.10428 · Cited by 3
Ramsey, S. D., Hall, I. J., Smith, J. L., Ekwueme, D. U., Fedorenko, C. R., Kreizenbeck, K. L., Bansal, A., Thompson, I. M., & Penson, D. F. (2020) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.07.014 · Cited by 3
Self-citationThe Role of PARP Activation in Prostate Cancer
Luis, A. (2013) · InTech eBooks · doi:10.5772/53297 · Cited by 3
Pharmacologic and surgical therapies for sexual dysfunction in male cancer survivors.
Kadıoğlu, A., Ortaç, M., & Brock, G. B. (2015) · PubMed Central · doi:10.3978/j.issn.2223-4683.2014.12.03 · Cited by 3
The Case for Including Bowel Urgency in Toxicity Reporting After Pelvic Cancer Treatment
Henson, C., Anandadas, C., Barraclough, L., Swindell, R., West, C., & Davidson, S. E. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0103 · Cited by 3
Victorson, D. E., Brucker, P. S., Bode, R. K., Eton, D. T., Talcott, J. A., Clark, J. A., Knight, S. J., Litwin, M. S., Moinpour, C. M., Reeve, B. B., et al. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.09.006 · Cited by 3
Kirby, R. S. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0210 · Cited by 3
Sexualidad y cáncer: toxidicidad y tratamientos de soporte
Ramírez, E. L., & González‐Flores, E. (2005) · Oncología (Barcelona) · doi:10.4321/s0378-48352005000300010 · Cited by 3
ECONOMIC EVALUATION OF DIAGNOSTIC LOCALIZATION FOLLOWING BIOCHEMICAL PROSTATE CANCER RECURRENCE
Barocas, D. A., Bensink, M. E., Berry, K., Musa, Z., Bodnar, C., Dann, R. A., & Ramsey, S. D. (2014) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462314000476 · Cited by 3
Obstacles of cancer survivorship: Sexuality issues - Need to break communication barriers
Sirsath, N. T., Lakshmaiah, K., Suresh, T., Babu, M. S., Babu, K., & Dasappa, L. (2014) · Clinical Cancer Investigation Journal · doi:10.4103/2278-0513.142614 · Cited by 3
Are we sleeping on the job? Insomnia among men with prostate cancer
Drummond, F. J. (2016) · Advances in Modern Oncology Research · doi:10.18282/amor.v2.i2.94 · Cited by 3
Complications of curative radiation treatment for early prostate cancer
James, M. L., McLean, G. T. Z., Williams, S. B., Robinson, B. A., & Ma, Y. (2018) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12839 · Cited by 3
Michalski, J. M., Pisansky, T. M., Lawton, C. A., & Potters, L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24098-7.00053-8 · Cited by 3
Management of the complications of external beam radiotherapy and brachytherapy
Loeb, S., & Nadler, R. B. (2006) · Current Prostate Reports · doi:10.1007/s11918-006-0017-9 · Cited by 3
Proceedings of the International Cancer Imaging Society (ICIS) 17th Annual Teaching Course
(2017) · Cancer Imaging · doi:10.1186/s40644-017-0126-4 · Cited by 3
Cryoablation for Prostate Cancer
Woodrum, D. A., Kawashima, A., Gorny, K. R., & Mynderse, L. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-51192-0_101-1 · Cited by 3
O'Connell, B. O., Baker, L., & Munro, I. (2007) · Contemporary Nurse · doi:10.5172/conu.2007.24.1.65 · Cited by 3
Management of Sexual Dysfunction
Rochira, V., Carani, C., & Granata, A. R. M. (2022) · doi:10.1093/med/9780198870197.003.0193 · Cited by 3
Oral BG-12 in Multiple Sclerosis
Sempere, Á. P., Berenguer-Ruiz, L., & Khabbaz, E. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1212740 · Cited by 3
Endocrine and Fertility Effects in Male Cancer Survivors
Thaler-DeMers, D. (2006) · Cancer Nursing · doi:10.1097/00002820-200603002-00023 · Cited by 3
Davuluri, M., DeMeo, G., Penukonda, S., Zahid, B., & Hu, J. C. (2023) · Current Urology Reports · doi:10.1007/s11934-023-01181-6 · Cited by 2
He, J., Li, L., Chen, S., Chen, R.-J., Zhuang, J.-L., Liu, C., Burrow, W., Chang, J., Tanziela, T., Bonfil, R. D., et al. (2026) · Technology in Cancer Research & Treatment · doi:10.1177/15330338261440434 · Cited by 4
A Review of Approaches to the Synthesis of DCL-Based Prostate-Specific Membrane Antigen Ligands
Zyk, N. Y., Butakova, N. S., Machulkin, A. E., & Beloglazkina, E. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104642 · Cited by 2
Helping Patients Make Treatment Choices for Localized Prostate Cancer
Mohan, R., Beydoun, H. A., & Schellhammer, P. F. (2012) · InTech eBooks · doi:10.5772/24571 · Cited by 2
How to implement the requirements of a quality assurance system for prostate cancer
Chiorda, B. N., Zollo, F., Magnani, T., Badenchini, F., Gatto, L., Claps, M., Macchi, A., Andreoli, L., Nicolai, N., Villa, S., et al. (2019) · World Journal of Urology · doi:10.1007/s00345-019-03024-x · Cited by 2
Wu, S., Huy, L. Đ., Liao, C. J., & Huang, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.875036 · Cited by 2
Triner, D. A., Johnson, K., Meah, S., Daignault‐Newton, S., Vaishampayan, N., Dhir, A., Labardee, C., Ferrante, S., Ginsburg, K., Lane, B. R., et al. (2024) · Urology · doi:10.1016/j.urology.2024.06.018 · Cited by 2
Takagi, H., Takeda, K., Kadoya, N., Inoue, K., Endo, S., Takahashi, N., Yamamoto, T., Umezawa, R., & Jingu, K. (2024) · Radiological Physics and Technology · doi:10.1007/s12194-024-00832-8 · Cited by 2
Anderson, P., Dogan, N., Ford, J. C., Padgett, K. R., Simpson, G., Stoyanova, R. S., Abramowitz, M. C., Pra, A. D., & Delgadillo, R. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1408752 · Cited by 2
Smoking and the risk of prostate cancer: a review of risk and disease progression
Sundaresan, I., Palanisamy, N., & Saraswathy, R. (2025) · Genes and Environment · doi:10.1186/s41021-025-00338-8 · Cited by 2
Fischer, J. (2018) · Oregon Undergraduate Research Journal · doi:10.5399/uo/ourj.12.1.2 · Cited by 2
The Impact of Prostate Cancer Diagnosis and Post-treatment Sexual Dysfunction on Quality of Life
Penson, D. F., & Nelson, C. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-555-2_2 · Cited by 2
Self-citationLiu, X., & Yetik, I. S. (2012) · Journal of Electronic Imaging · doi:10.1117/1.jei.21.2.023008 · Cited by 2
Quality of life and satisfaction with outcome among prostate-cancer survivors
Penson, D. F. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.07.029 · Cited by 2
Self-citationAnandadas, C., Davidson, S. E., Clarke, N. W., Brown, S. C. W., Logue, J. P., Gilmore, L., Swindell, R., Collins, G. N., O’Reilly, P. H., Wemyss-Holden, G. D., et al. (2011) · Journal of Cancer Therapy · doi:10.4236/jct.2011.24060 · Cited by 2
Palacios, L. A. G., Krouwel, E. M., Oudsten, B. L. D., den Ouden, M. E. M., Kloens, G. J., van Duijn, G., Putter, H., Pelger, R. C. M., & Elzevier, H. W. (2017) · Tijdschrift voor Urologie · doi:10.1007/s13629-017-0172-5 · Cited by 2
Targeted Prostate Biopsy and MR-Guided Therapy for Prostate Cancer
Woodrum, D. A., Kawashima, A., Górny, K., & Mynderse, L. A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-99286-0_9 · Cited by 2
Zhang, L., Hsieh, M., Allison, C., Devane, A. M., Hicks, C., Yu, Q., Shi, L., Wu, J., & Wu, X. (2021) · Cancer Epidemiology · doi:10.1016/j.canep.2021.101967 · Cited by 2
Metadata
- Authors
- Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Potosky, A. L.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09-14
- Volume
- 96
- Issue
- 18
- Pages
- 1358-1367
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2160612556
- Cited by
- 680
- References
- 42
- Citations by year
- 2026: 15 · 2025: 8 · 2024: 16 · 2023: 15 · 2022: 12 · 2021: 15 · 2020: 19 · 2019: 18 · 2018: 26 · 2017: 30 · 2016: 28 · 2015: 32 · 2014: 47 · 2013: 54 · 2012: 55
- FWCI
- 32.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institutes of Health (n01pc067010-004, n01pc067009-004, n01pc067000-000, n01pc067005-009, n01pc067007-017, N01-PC67010, n01pc067006-000)
- National Cancer Institute (N01-PC-67010, N01-PC-67006, N01 PC-67009, N01 PC67000, N01-PC-67007, N01 PC 67005)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
- Keywords
- prostate cancer, radical prostatectomy, external beam radiotherapy, quality of life, erectile dysfunction, urinary incontinence, bowel function, sexual function, long-term treatment outcomes, localized prostate cancer
- MeSH terms
- Aged, Fecal Incontinence, Humans, Erectile Dysfunction, Male, Middle Aged, Prospective Studies, Prostatectomy, Prostatic Neoplasms, Quality of Life, Surveys and Questionnaires, Research Design, Socioeconomic Factors, Urinary Incontinence, Selection Bias, Logistic Models, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review